This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, C. Articles by Edgington, T. Search for Related Content PubMed PubMed Citation Articles by Liu, C. Articles by Edgington, T.

Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy¹

Departments of Immunology [C. L., H. H., T. E.] and Chemistry [C. S., K. J.], The Scripps Research Institute, La Jolla, California 92037-1092

Expression of legumain, a novel asparaginyl endopeptidase, in tumors was identified from gene expression profiling and tumor tissue array analysis. Legumain was demonstrated in membrane-associated vesicles concentrated at the invadopodia of tumor cells and on cell surfaces where it colocalized with integrins. Legumain was demonstrated to activate progelatinase A. Cells overexpressing legumain possessed increased migratory and invasive activity in vitro and adopted an invasive and metastatic phenotype in vivo, inferring significance of legumain in tumor invasion and metastasis. A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed. The prototype compound, designated legubicin, exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.

This article has been cited by other articles:

				J. C. Strefford, F. W. van Delft, H. M. Robinson, H. Worley, O. Yiannikouris, R. Selzer, T. Richmond, I. Hann, T. Bellotti, M. Raghavan, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 PNAS, May 23, 2006; 103(21): 8167 - 8172. [Abstract] [Full Text] [PDF]

				W. Wu, Y. Luo, C. Sun, Y. Liu, P. Kuo, J. Varga, R. Xiang, R. Reisfeld, K. D. Janda, T. S. Edgington, et al. Targeting Cell-Impermeable Prodrug Activation to Tumor Microenvironment Eradicates Multiple Drug-Resistant Neoplasms Cancer Res., January 15, 2006; 66(2): 970 - 980. [Abstract] [Full Text] [PDF]

				R. Richter, R. Bistrian, S. Escher, W.-G. Forssmann, J. Vakili, R. Henschler, N. Spodsberg, A. Frimpong-Boateng, and U. Forssmann Quantum Proteolytic Activation of Chemokine CCL15 by Neutrophil Granulocytes Modulates Mononuclear Cell Adhesiveness J. Immunol., August 1, 2005; 175(3): 1599 - 1608. [Abstract] [Full Text] [PDF]

				S. Datta and S. Datta Empirical Bayes screening of many p-values with applications to microarray studies Bioinformatics, May 1, 2005; 21(9): 1987 - 1994. [Abstract] [Full Text] [PDF]

				R. V. Murthy, G. Arbman, J. Gao, G. D. Roodman, and X.-F. Sun Legumain Expression in Relation to Clinicopathologic and Biological Variables in Colorectal Cancer Clin. Cancer Res., March 15, 2005; 11(6): 2293 - 2299. [Abstract] [Full Text] [PDF]

				C. Liu, C. Dickinson, J. Shobe, F. Donate, W. Ruf, and T. Edgington A hybrid fibronectin motif protein as an integrin targeting selective tumor vascular thrombogen Mol. Cancer Ther., July 1, 2004; 3(7): 793 - 801. [Abstract] [Full Text] [PDF]